> top > docs > PMC:7441788 > spans > 20224-20467 > annotations

PMC:7441788 / 20224-20467 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T111 172-183 Body_part denotes nasopharynx http://purl.org/sig/ont/fma/fma54878

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T10 172-183 Body_part denotes nasopharynx http://purl.obolibrary.org/obo/UBERON_0001728

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T247 24-29 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T248 100-112 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T12 184-194 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T139 100-112 Chemical denotes azithromycin http://purl.obolibrary.org/obo/CHEBI_2955

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T152 0-243 Sentence denotes Observational study HCQ group: n = 80; no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly.

LitCovid-sample-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T9 172-183 Body_part denotes nasopharynx http://purl.obolibrary.org/obo/UBERON_0001728

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T110 172-183 Body_part denotes nasopharynx http://purl.org/sig/ont/fma/fma54878

LitCovid-sample-PD-MAT

Id Subject Object Predicate Lexical cue
T6 172-183 http://purl.obolibrary.org/obo/MAT_0000447 denotes nasopharynx

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T152 0-243 Sentence denotes Observational study HCQ group: n = 80; no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly.